[HTML][HTML] Neisseria meningitidis: pathogenesis and immunity

M Pizza, R Rappuoli - Current opinion in microbiology, 2015 - Elsevier
Highlights•Pili minor components play a key role in the regulation of pili mediated
activities.•Adhesion is a multifactorial effect; adhesins may function in an orchestrated …

Structural vaccinology starts to deliver

PR Dormitzer, G Grandi, R Rappuoli - Nature Reviews Microbiology, 2012 - nature.com
Following the impact of the genomics revolution on vaccine research and the development
of reverse vaccinology, it was predicted that another new approach, structure-based antigen …

Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen

E Malito, A Faleri, P Lo Surdo… - Proceedings of the …, 2013 - National Acad Sciences
Mapping of epitopes recognized by functional monoclonal antibodies (mAbs) is essential for
understanding the nature of immune responses and designing improved vaccines …

Emerging experience with meningococcal serogroup B protein vaccines

D Toneatto, M Pizza, V Masignani… - Expert review of …, 2017 - Taylor & Francis
Introduction: The successful development of two broadly protective vaccines targeting
Neisseria meningitidis serogroup B (MenB); 4CMenB and rLP2086, is the most significant …

Self-assembling protein nanoparticles and virus like particles correctly display β-barrel from meningococcal factor H-binding protein through genetic fusion

L Cappelli, P Cinelli, F Giusti, I Ferlenghi… - PLoS …, 2022 - journals.plos.org
Recombinant protein-based vaccines are a valid and safer alternative to traditional vaccines
based on live-attenuated or killed pathogens. However, the immune response of subunit …

Product review on the IMD serogroup B vaccine Bexsero®

AE Deghmane, MK Taha - Human vaccines & immunotherapeutics, 2022 - Taylor & Francis
Bexsero® is a multicomponent vaccine composed of four major proteins of Neisseria
meningitidis: the fHbp, NHBA, NadA and PorA. This vaccine was licensed against invasive …

Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined

M Biagini, M Spinsanti, G De Angelis… - Proceedings of the …, 2016 - National Acad Sciences
Factor H binding protein (fHbp) is a lipoprotein of Neisseria meningitidis important for the
survival of the bacterium in human blood and a component of two recently licensed vaccines …

Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen

KL Seib, M Scarselli, M Comanducci… - Expert review of …, 2015 - Taylor & Francis
Neisseria meningitidis is a leading cause of meningitis and sepsis worldwide. The first broad-
spectrum multicomponent vaccine against serogroup B meningococcus (MenB), 4CMenB …

The surface lipoproteins of gram-negative bacteria: Protectors and foragers in harsh environments

GB Cole, TJ Bateman, TF Moraes - Journal of Biological Chemistry, 2021 - ASBMB
Gram-negative pathogens are enveloped by an outer membrane that serves as a double-
edged sword: On the one hand, it provides a layer of protection for the bacterium from …

Protein crystallography in vaccine research and development

E Malito, A Carfi, MJ Bottomley - International Journal of Molecular …, 2015 - mdpi.com
The use of protein X-ray crystallography for structure-based design of small-molecule drugs
is well-documented and includes several notable success stories. However, it is less well …